Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Squamous Cell Carcinoma of Head and Neck 2Stomach Neoplasms 1Rectal Neoplasms 1Pancreatic Adenocarcinoma Metastatic 1Osteosarcoma 1Gastrointestinal Neoplasms 1Gastrointestinal Diseases 1Digestive System Diseases 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1Carcinoma 1Advanced Solid Tumor 1Advanced Pancreatic Cancer 1

Interventions

penpulimab 1lutetium Lu 177 dotatate 1copper dotatate CU-64 1XELOX 1Oxaliplatin 1Lutetium-177 1Lutetium 1IDRX-42 1Drug Therapy 1Colonoscopy 1Capecitabine 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Digestive System Diseases × penpulimab × Clear all
NCT05494060 2023-11-07

EXPLORING

The First Affiliated Hospital with Nanjing Medical University

Phase 2 Recruiting
80 enrolled
Gastrointestinal

Carcinoma, Digestive System Diseases, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡